Enlivex Therapeutics Ltd (NASDAQ:ENLV)
| 2.69 Delayed Data As of Jun 09 |  -0.01 / -0.37%Today’s Change | 2.23 Today|||52-Week Range 6.15 | -31.68% Year-to-Date |
Latest ENLV News | Press Releases
No recent news for Enlivex Therapeutics Ltd.
Today’s Trading
| Previous close | 2.70 |
| Today’s open | 2.69 |
| Day’s range | 2.69 - 2.69 |
| Volume | 73 |
| Average volume (3 months) | 31,930 |
| Market cap | $50.9M |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -108.43% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Implanet SA | 0.00 | 0.00% |
| APTAlpha Pro Tech Ltd | -0.07 | -1.79% |
| RWLKRewalk Robotics Ltd | +0.01 | +1.30% |
| VANIVivani Medical Inc | -0.15 | -10.49% |
Data as of 3:57pm ET, 06/09/2023
Financials
| Next reporting date | August 7, 2023 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$31.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Ness Ziona, Tel Aviv |
Forecasts
